MUMBAI, India, July 7 -- Intellectual Property India has published a patent application (202641058020 A) filed by Saveetha Institute Of Medical And Technical Sciences on May 07, 2026, for Bioengineered Chitosan-Polyvinyl Alcohol-Polyethylene Glycol Hydrogel Incorporating Ciprofloxacin And Flaxseed Exrtract For Regenrative Wound Healing..
Inventors include S. Hemavathy; Dr. Vinay Kumar; and Deepak Nallaswamy Veeraiyan.
The application for the patent was published on July 03, 2026, under issue no. 27/2026.
Abstract: ABSTRACT: The invention presents a bioengineered hydrogel formulated from chitosan, polyvinyl alcohol, and polyethylene glycol, incorporating ciprofloxacin and flaxseed extract for regenerative wound healing. The polymeric network provides hydration, adhesion, and structural stability, while ciprofloxacin delivers sustained antibacterial action. Flaxseed extract contributes antioxidant and soothing effects that support tissue repair. Crosslinking enables controlled release of functional components, making the hydrogel suitable for wounds, burns, and ulcer management.
Disclaimer: Curated by HT Syndication.
